OsteoSelect Demineralized Bone Matrix (DBM) Putty 10.0cc in a syringe; STERILE R, Product Code: 359100, Dimensions: ONE(1) PACKAGE - CONTAINING 10.0cc. UDI: 00849777003681 - Product Usage: OsteoSelect DBM Putty is indicated for use as a bone void filler and bone graft substitute for voids or gaps that are not intrinsic to the stability of the bony structure. OsteoSelect DBM Putty is indicated for treatment of surgically created osseous defects or osseous defects from traumatic injury to the bone. OsteoSelect DBM Putty can be used as follows: - Extremities - Posterolateral spine - Pelvis.
Published March 25, 2020 · Recall initiated: May 3, 2019
Summary
FDA records medical device Class II recall Z-1526-2020, published March 25, 2020 and initiated May 3, 2019. Recalling firm: XTANT MEDICAL INC; Status: Terminated; Reported quantity: 26; Lot: Lot/Serial numbers: B180228-751 through B180228-779;Model/Product Code: 359100;the expiration date of these devices is 2021-06-05. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The firm received one customer complaint concerning three OsteoSelect Demineralized Bone Matrix (DBM) devices which contained 5.0cc of putty, instead of 10.00cc of putty as labeled.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- XTANT MEDICAL INC
- Distributor
- US Nationwide Distribution in the states of AZ,CA, NC, NJ, NY, PA, SC, TX, and WA. There were no OUS consignees.
- Lot
- Lot/Serial numbers: B180228-751 through B180228-779;Model/Product Code: 359100;the expiration date of these devices is 2021-06-05.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAColostat, Homeopathic Remedy, 1 fl. oz. (30 mL) per bottle, 20% Ethanol, Dist. by Energique, Inc., 201 AppleApril 1, 2020
- FDABuprexone Banana cream 6-0.6 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, ThriveApril 1, 2020
- FDABuprenorphine Watermelon 8 mg Troche, supplied in plastic troche molds with cardboard outer sleeve, ThriveApril 1, 2020
- FDAMedtronic CareLink 2090 Programmer. Used to interrogate and program Medtronic and Vitatron implantableMarch 25, 2020
- FDACustom procedure trays containing medical components needed to facilitate patient procedures and to performMarch 25, 2020
- FDACustom procedure trays containing medical components needed to facilitate patient procedures and to performMarch 25, 2020
Questions about this recall
Was OsteoSelect Demineralized Bone Matrix (DBM) Putty 10.0cc in a syringe; STERILE R, Product Code: 359100, Dimensions: ONE(1) PACKAGE - CONTAINING 10.0cc. UDI: 00849777003681 - Product Usage: OsteoSelect DBM Putty is indicated for use as a bone void filler and bone graft substitute for voids or gaps that are not intrinsic to the stability of the bony structure. OsteoSelect DBM Putty is indicated for treatment of surgically created osseous defects or osseous defects from traumatic injury to the bone. OsteoSelect DBM Putty can be used as follows: - Extremities - Posterolateral spine - Pelvis. recalled?
Yes. FDA published recall Z-1526-2020 on March 25, 2020. Reported hazard: The firm received one customer complaint concerning three OsteoSelect Demineralized Bone Matrix (DBM) devices which contained 5.0cc of putty, instead of 10.00cc of putty as labeled.
What should I do if I have this product?
Voluntary: Firm initiated · Letter